Research ArticleClinical Review

Sudden Sensorineural Hearing Loss: A Diagnostic and Therapeutic Emergency

Andrew D. P. Prince and Emily Z. Stucken
The Journal of the American Board of Family Medicine January 2021, 34 (1) 216-223; DOI: https://doi.org/10.3122/jabfm.2021.01.200199

References

  1. 1.↵
    1. Dallan I,
    2. Fortunato S,
    3. Casani A,
    4. et al
    . Long-term follow up of sudden sensorineural hearing loss patients treated with intratympanic steroids: audiological and quality of life evaluation. J Laryngol Otol 2014;128:669–73.
    OpenUrl
  2. 2.↵
    1. Rauch S
    . Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833–40.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Stew B,
    2. Fishpool S,
    3. Williams H
    . Sudden Sensorineural hearing loss. Brit J Hosp Med 2012;73:86–9.
    OpenUrl
  4. 4.↵
    1. Alexander T,
    2. Harris J
    . Incidence of sudden sensorineural hearing loss. Otol Neurotol 2013;34:1586–9.
    OpenUrl
  5. 5.↵
    1. Mattox D,
    2. Simmons F
    . Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–80.
    OpenUrlPubMedWeb of Science
  6. 6.↵
    1. Byl F
    . Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope 1977;87:817–25.
    OpenUrlPubMedWeb of Science
  7. 7.↵
    1. Chandrasekhar S,
    2. Tsai Do B,
    3. Schwartz S,
    4. et al
    . Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg 2019;161:195–210.
    OpenUrlPubMed
  8. 8.↵
    1. Stachler R,
    2. Chandrasekhar S,
    3. Archer S,
    4. et al
    . Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146:S1–S35.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Cabana M,
    2. Rand C,
    3. Powe N,
    4. et al
    . Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458–65.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Ryan M
    . Adherence to clinical practice guidelines. Otolaryngol Head Neck Surg 2017;157:548–50.
    OpenUrl
  11. 11.↵
    1. Witsell D,
    2. Khoury T,
    3. Schulz K,
    4. et al
    . Evaluation of compliance for treatment of sudden hearing loss: a CHEER Network study. Otolaryngol Head Neck Surg 2016;155:48–55.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Federspil P
    . Drug-induced sudden hearing loss and vestibular disturbances. Adv Otorhinolaryngol 1981;27:144–58.
    OpenUrlPubMed
  13. 13.↵
    1. Govindaraju R,
    2. Omar R,
    3. Rajagopalan R,
    4. Norlisah R,
    5. Kwan-Hoong N
    . Hearing loss after noise exposure. Auris Nasus Larynx 2011;38:519–22.
    OpenUrlPubMed
  14. 14.↵
    1. Norris C
    . Drugs affecting the inner ear: a review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy. Drugs 1988;36:754–72.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Saunders J,
    2. Luxford W,
    3. Devgan K,
    4. Fetterman B
    . Sudden hearing loss in acoustic neuroma patients. Otolaryngol Head Neck Surg 1995;113:23–31.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Tunkel D,
    2. Bauer C,
    3. Sun G,
    4. et al
    . Clinical practice guideline: tinnitus. Otolaryngol Head Neck Surg 2014;151:S1–S40.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Niu X,
    2. Zhang Y,
    3. Zhang Q,
    4. et al
    . The relationship between hearing loss and vestibular dysfunction in patients with sudden sensorineural hearing loss. Acta Otolaryngol 2016;136:225–31.
    OpenUrlPubMed
  18. 18.↵
    1. Chiossoine-Kerdel J,
    2. Baguley D,
    3. Stoddart R,
    4. Moffat D
    . An investigation of the audiologic handicap associated with unilateral sudden sensorineural hearing loss. Am J Otol 2000;21:645–51.
    OpenUrlPubMed
  19. 19.↵
    1. Rosenfeld R,
    2. Shin J,
    3. Schwartz S,
    4. et al
    . Clinical practice guideline: otitis media with effusion (update). Otolaryngol Head Neck Surg 2016;154:S1–S41.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Schwartz S,
    2. Magit A,
    3. Rosenfeld R,
    4. et al
    . Clinical practice guideline (update): earwax (cerumen impaction). Otolaryngol Head Neck Surg 2017;156:S1–S29.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Ahmed O,
    2. Gallant S,
    3. Ruiz R,
    4. et al
    . Validity of the hum test, a simple and reliable alternative to the Weber test. Ann Otol Rhinol Laryngol 2018;127:402–5.
    OpenUrl
  22. 22.↵
    1. Conte G,
    2. Berardino D,
    3. Sina C,
    4. et al
    . MR imaging in sudden sensorineural hearing loss: time to talk. AJNR Am J Neuroradiol 2017;38:1475–9.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Abele T,
    2. Besachio D,
    3. Quigley E,
    4. et al
    . Diagnostic accuracy of screening MR imaging using unenhanced axial CISS and coronal T2WI for detection of small internal auditory canal lesions. AJNR Am J Neuroradiol 2014;35:2366–70.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Chandrasekhar S,
    2. Brackmann D,
    3. Devgan K
    . Utility of auditory brainstem response audiometry in diagnosis of acoustic neuromas. Am J Otol 1995;16:63–7.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    1. Schmidt R,
    2. Sataloff R,
    3. Newman J,
    4. Spiegel J,
    5. Myers D
    . The sensitivity of auditory brainstem response testing for the diagnosis of acoustic neuromas. Arch Otolaryngol Head Neck Surg 2001;127:19–22.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Haynes DS,
    2. O’Malley M,
    3. Cohen S,
    4. Watford K,
    5. Labadie RF
    . Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3–15.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Chen C,
    2. Halpin C,
    3. Rauch S
    . Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol 2003;24:728–33.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Silverstein H,
    2. Choo D,
    3. Rosenberg SI,
    4. Kuhn J,
    5. Seidman M,
    6. Stein I
    . Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996;75:468–71.
    OpenUrlPubMed
  29. 29.↵
    1. Spear S,
    2. Schwartz S
    . Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011;145:534–43.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Parnes L,
    2. Sun A,
    3. Freeman D
    . Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed-up by clinical application. Laryngoscope 1999;109:1–17.
    OpenUrlPubMedWeb of Science
  31. 31.↵
    1. Chandrasekhar S
    . Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18–23.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Battaglia A,
    2. Burchette R,
    3. Cueva R
    . Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otology & Neurotology 2008;29:453–60.
    OpenUrl
  33. 33.↵
    1. Ahn HJ,
    2. Han WM,
    3. Kim HJ,
    4. Chung WJ,
    5. Yoon TH
    . Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 2008;128:128–31.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Crane R,
    2. Camilon M,
    3. Nguyen S,
    4. Meyer T
    . Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Laryngoscope 2015;125:209–17.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Garavello W,
    2. Galluzzi F,
    3. Gaini R,
    4. Zanetti D
    . Intratympanic steroid treatment for sudden deafness: a meta-analysis of randomized controlled trials. Otol Neurotol 2012;33:724–9.
    OpenUrlPubMed
  36. 36.↵
    1. Mirian C,
    2. Oveseen T
    . Intratympanic vs systemic corticosteroids in first-line treatment of idiopathic sudden sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg 2020;146:421–428.
    OpenUrl
  37. 37.↵
    1. Lim HJ,
    2. Kim YT,
    3. Choi SJ,
    4. et al
    . Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Otolaryngol Head Neck Surg 2013;148:121–7.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Rauch SD,
    2. Halpin CF,
    3. Antonelli PJ,
    4. et al
    . Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 2011;305:2071–9.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Kavita S,
    2. Dinesh S,
    3. Jatinder S
    . Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. J Basic Clin Physiol Pharmacol 2016;27:371–7.
    OpenUrl
  40. 40.↵
    1. Ahn JH,
    2. Yoo MH,
    3. Yoon TH,
    4. Chung JW
    . Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope 2008;118:279–82.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Fisch U,
    2. Nagahara K,
    3. Pollak A
    . Sudden hearing loss: circulatory. Am J Otol 1984;5:488–91.
    OpenUrlPubMed
  42. 42.↵
    1. Li Y
    . Interventions in the management of blood viscosity for idiopathic sudden sensorineural hearing loss: a meta-analysis. J Health Res Rev 2017;4:50–61.
    OpenUrl
  43. 43.↵
    1. Gill A,
    2. Bell C
    . Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 2004;97:385–95.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Bennett M,
    2. Kertesz T,
    3. Perleth M,
    4. Yeung P,
    5. Lehm J
    . Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2012;10:CD0043739.
    OpenUrl
  45. 45.↵
    1. Yang C,
    2. Wu R,
    3. Hwang C
    . Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss. Otol Neurotol 2013;34:1411–6.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Moon I,
    2. Lee J,
    3. Kim J,
    4. Hong S,
    5. Lee W
    . Intratympanic dexamethasone is an effective method as a salvage treatment in refractory sudden hearing loss. Otol Neurotol 2011;32:1432–6.
    OpenUrlPubMed
  47. 47.↵
    1. de Oliveira Penido N,
    2. Ramos HVL,
    3. Barros FA,
    4. Cruz OLM,
    5. Toledo RN
    . Clinical, etiological and progression factors of hearing in sudden deafness. Brazil J Otorhinolaryngol 2005;71:633–8.
    OpenUrl
  48. 48.↵
    1. Hol M,
    2. Bosman A,
    3. Snik A,
    4. Mylanus E,
    5. Cremers C
    . Bone-anchored hearing aids in unilateral inner ear deafness: an evaluation of audiometric and patient outcome measurements. Otol Neurotol 2005;26:999–1006.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Blasco M,
    2. Redleaf M
    . Cochlear implantation in unilateral sudden deafness improves tinnitus and speech comprehension: meta-analysis and systematic review. Otol Neurotol 2014;35:1426–32.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Gaylor JM,
    2. Raman G,
    3. Chung M,
    4. et al
    . Cochlear implantation in adults: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 2013;139:265–72.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords